Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Emory University
We hypothesize that by presenting a novel odor to a patient in a state of deep relaxation, the odor will serve as a conditioned inhibitory stimulus, or safety signal, in anxiety-provoking situations. With the odor serving as a contextual cue for the state of relaxation.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
GAD without a comorbid active major psychiatric disorder.
GAD must be the primary active psychiatric disorder.
GAD determined via the Mini International Neuropsychiatric Interview (MINI).
You may not be if
Significant medical illness that might interfere with the relaxation therapy or with training using the odorant.
Actively abusing alcohol.
Illicit substances.
Currently using rapid-acting anxiolytic agents (e.g. benzodiazepines, hydroxyzine).
Started an antidepressant, antipsychotic or mood stabilizing agent within three months of screening visit.
Clareo Health | Muscle Relaxation Therapy With Odorant Cue
